ASEAN Medicine Trade Barriers Lowered

To read the full article, please choose one of the following options:

BMI expects more drugmakers in South East Asia to get Good Manufacturing Practice (GMP) accreditation after a major trade agreement was signed. Upgrading facilities and processes will require considerable investment in the short term, but producers of pharmaceuticals will eventually see a significant upside, both domestically and abroad. This is because consumers, especially those on those low incomes, will increasingly appreciate the quality of medicines made in the region.